ArticlePharmaceuticals (Basel, Switzerland)2025

Semaglutide in MASLD Patients: Improved Survival and Liver Outcomes.

Mohamad Suki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.